BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28093788)

  • 1. North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer.
    Leyh-Bannurah SR; Budäus L; Pompe R; Zaffuto E; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Huland H; Graefen M; Karakiewicz PI
    Prostate; 2017 Apr; 77(5):542-548. PubMed ID: 28093788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.
    Leyh-Bannurah SR; Budäus L; Zaffuto E; Pompe RS; Bandini M; Briganti A; Montorsi F; Schiffmann J; Shariat SF; Fisch M; Chun F; Huland H; Graefen M; Karakiewicz PI
    Urol Oncol; 2018 Feb; 36(2):81.e17-81.e24. PubMed ID: 29248430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy.
    Abdollah F; Schmitges J; Sun M; Shariat SF; Briganti A; Abdo A; Tian Z; Perrotte P; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Apr; 109(8):1177-82. PubMed ID: 21880105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy.
    Abdollah F; Sun M; Briganti A; Thuret R; Schmitges J; Gallina A; Suardi N; Capitanio U; Salonia A; Shariat SF; Perrotte P; Rigatti P; Montorsi F; Karakiewicz PI
    BJU Int; 2011 Dec; 108(11):1769-75. PubMed ID: 21507189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.
    Schmitges J; Karakiewicz PI; Sun M; Abdollah F; Budäus L; Isbarn H; Bianchi M; Trinh QD; Schlomm T; Chun FK; Graefen M; Steuber T
    Eur J Surg Oncol; 2012 Jul; 38(7):624-9. PubMed ID: 22531769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy.
    Bandini M; Marchioni M; Pompe RS; Tian Z; Gandaglia G; Fossati N; Abdollah F; Graefen M; Montorsi F; Saad F; Shariat SF; Briganti A; Karakiewicz PI
    BJU Int; 2018 Apr; 121(4):592-599. PubMed ID: 29124911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients.
    Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Dell'Oglio P; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Graefen M; Karakiewicz PI
    Prostate; 2017 Jan; 77(1):105-113. PubMed ID: 27683103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
    Abdollah F; Schmitges J; Sun M; Thuret R; Djahangirian O; Tian Z; Shariat SF; Briganti A; Perrotte P; Montorsi F; Karakiewicz PI
    Urology; 2011 Dec; 78(6):1363-7. PubMed ID: 22137704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
    Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
    Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy.
    Dell'Oglio P; Abdollah F; Suardi N; Gallina A; Cucchiara V; Vizziello D; Zaffuto E; Cantiello F; Damiano R; Shariat S; Montorsi F; Briganti A
    J Endourol; 2014 Apr; 28(4):416-23. PubMed ID: 24188052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
    Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
    Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Comprehensive Cancer Network practice guidelines 2011: Need for more accurate recommendations for pelvic lymph node dissection in prostate cancer.
    Abdollah F; Sun M; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni N; Karakiewicz PI; Rigatti P; Montorsi F; Briganti A;
    J Urol; 2012 Aug; 188(2):423-8. PubMed ID: 22698627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.
    Bandini M; Marchioni M; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Shariat SF; Montorsi F; Saad F; Briganti A; Tilki D; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):449-456. PubMed ID: 29249688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
    Gandaglia G; Martini A; Ploussard G; Fossati N; Stabile A; De Visschere P; Borgmann H; Heidegger I; Steinkohl F; Kretschmer A; Marra G; Mathieu R; Surcel C; Tilki D; Tsaur I; Valerio M; Van den Bergh R; Ost P; Gontero P; Montorsi F; Briganti A;
    Eur Urol; 2020 Aug; 78(2):138-142. PubMed ID: 32268944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database.
    Chen J; Wang Z; Zhao J; Zhu S; Sun G; Liu J; Zhang H; Zhang X; Shen P; Shi M; Zeng H
    Sci Rep; 2019 Nov; 9(1):17985. PubMed ID: 31784574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting lymph node invasion in patients treated with robot-assisted radical prostatectomy.
    Abdollah F; Klett DE; Sammon JD; Dalela D; Sood A; Hsu L; Diaz M; Gupta N; Peabody JO; Trinh QD; Menon M
    Can J Urol; 2016 Feb; 23(1):8141-50. PubMed ID: 26892054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
    Hansen J; Rink M; Bianchi M; Kluth LA; Tian Z; Ahyai SA; Shariat SF; Briganti A; Steuber T; Fisch M; Graefen M; Karakiewicz PI; Chun FK
    Prostate; 2013 Jan; 73(2):211-8. PubMed ID: 22821742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.